Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$4,471,475
+$1,108,796 QoQ
Shares Held
3,728
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,802
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westover Capital Advisors, LLC holds $13,813,106 across 9 Drug Manufacturers - General names. LLY ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,728 | $4,471,475 | |
| 2 | ABBV |
AbbVie Inc.
|
8,549 | $2,151,270 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
15,885 | $2,006,910 | |
| 4 | JNJ |
Johnson & Johnson
|
6,016 | $1,527,883 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,716 | $1,505,506 | |
| 6 | AMGN |
Amgen Inc
|
2,375 | $860,035 | |
| 7 | AZN |
Astrazeneca PLC
|
4,458 | $845,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,182 | $240,966 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,471,475 | 3,728 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,362,679 | 3,656 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,225,662 | 2,071 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,437,492 | 1,884 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,562,178 | 2,004 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,660,079 | 2,010 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,636,640 | 2,120 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,879,964 | 2,122 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,759,153 | 1,943 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,490,571 | 1,916 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,116,874 | 1,916 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,213,913 | 2,260 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,059,894 | 2,260 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $776,472 | 2,261 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $826,432 | 2,259 | Shares | Sole | 2023-05-18 | |
| 2022-09-30 | $745,645 | 2,306 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $747,674 | 2,306 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $660,369 | 2,306 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $636,963 | 2,306 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $532,801 | 2,306 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $529,273 | 2,306 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $431,927 | 2,312 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $397,111 | 2,352 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $318,539 | 2,152 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $353,315 | 2,152 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $233,743 | 1,685 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||